椎旁神经阻滞在组织扩张器乳房再造中的应用:倾向性匹配分析阿片类药物消耗与患者结局
本回顾性研究对2017年12月至2019年9月接受组织扩张器乳房再造的患者进行倾向性匹配,比较术前椎旁神经阻滞(PVB)组与无阻滞组的围手术期镇痛药使用、出院后疼痛评分及BREAST-Q躯体健康评分。匹配队列共471例(PVB组314例,无阻滞组157例)。PVB组吗啡毫克当量消耗显著少于无阻滞组(53.7 vs 69.8;P < 0.001),术后6周BREAST-Q躯体健康评分显著高于无阻滞组(60.6 vs 51.0;P = 0.015),但出院后疼痛评分两组相当。
要点
- PVB组吗啡毫克当量消耗53.7,显著低于无阻滞组的69.8(P < 0.001)。
- 术后6周BREAST-Q躯体健康评分PVB组60.6,显著高于无阻滞组51.0(P = 0.015)。
- 出院后第2至10天疼痛评分两组相当,最大差异为0.3分(0-4分量表)。
核心结论
- PVB可能有助于减少围手术期阿片类药物需求,但作为基于扩张器的乳房再造围手术期疼痛管理方案的一部分,并未降低出院后的疼痛评分。
研究设计与样本
- 回顾性综述,纳入2017年12月至2019年9月接受组织扩张器乳房再造的患者,按倾向性评分以2例PVB患者匹配1例无阻滞患者。
- 倾向性匹配队列共471例(PVB组314例,无阻滞组157例)。
主要发现
- PVB组吗啡毫克当量消耗显著少于无阻滞组(53.7 vs 69.8;P < 0.001)。
- 出院后第2至10天平均每日术后疼痛严重程度评分两组相当,最大差异为0.3分(0-4分量表)。
- 术后6周BREAST-Q躯体健康评分PVB组显著高于无阻滞组(60.6 vs 51.0;P = 0.015),术后2周和3个月时无显著差异。
临床怎么用
- 作者认为PVB可能有助于减少围手术期阿片类药物需求,但未降低出院后疼痛评分。
- 作者建议继续研究其他或替代的区域阻滞操作,以及PVB的经济成本和潜在长期影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The paravertebral block (PVB) is an adjunctive perioperative pain control method for patients undergoing breast reconstruction that may improve perioperative pain control and reduce narcotic use. This study determined the efficacy of preoperative PVBs for perioperative pain management in patients undergoing tissue expander breast reconstruction. METHODS: A retrospective review was performed of patients who underwent tissue expander breast reconstruction from December of 2017 to September of 2019. Two patients with PVBs were matched using propensity scoring to one no-block patient. Perioperative analgesic use, pain severity scores on days 2 to 10 after discharge, and BREAST-Q Physical Well-Being scores before surgery and at 2 weeks, 6 weeks, and 3 months after surgery were compared between the two groups. RESULTS: The propensity-matched cohort consisted of 471 patients (314 PVB and 157 no block). The PVB group used significantly fewer morphine milligram equivalents than the no-block group (53.7 versus 69.8; P < 0.001). Average daily postoperative pain severity scores were comparable, with a maximum difference of 0.3 points on a 0-point to 4-point scale. BREAST-Q Physical Well-Being scores were significantly higher for the PVB group than the no-block group at 6 weeks after surgery (60.6 versus 51.0; P = 0.015) but did not differ significantly at 2 weeks or 3 months after surgery. CONCLUSIONS: PVBs may help reduce perioperative opioid requirements but did not reduce pain scores after discharge when used as part of an expander-based reconstruction perioperative pain management protocol. Continued research should examine additional or alternative regional block procedures as well as financial cost and potential long-term impact of PVBs. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Shamsunder MG, Chu JJ, Taylor E, et al. Paravertebral Blocks in Tissue Expander Breast Reconstruction: Propensity-Matched Analysis of Opioid Consumption and Patient Outcomes. Plast Reconstr Surg. 2022. PMID: 36729942. doi:10.1097/PRS.0000000000009981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。